Incidental Diagnosis of Mantle Lymphoma Made by Sigmoidoscopy
نویسندگان
چکیده
منابع مشابه
Incidental Diagnosis of Mantle Lymphoma Made by Sigmoidoscopy
A 82-year-old man has been followed in our oncology hospital after prostatic cancer and prostatectomy. He was medicated with gonadotropin releasing hormone superagonist goserelin and olmesartan for arterial hypertension. Due to the recent installation of orthopnea, a chest X-ray was carried out, revealing a mass in the right hilar region which was subsequently characterized as right hilar and m...
متن کاملIn situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior.
BACKGROUND Cyclin D1-positive B cells are occasionally found in the mantle zones of reactive lymphoid follicles, a condition that has been called "in situ mantle cell lymphoma". The clinical significance of this lesion remains uncertain. DESIGN AND METHODS The clinical and pathological characteristics, including SOX11 expression, of 23 cases initially diagnosed as in situ mantle cell lymphoma...
متن کاملA Diagnosis Made by 'Facilitation'.
Lambert Eaton myasthenic syndrome is a presynaptic neuromuscular junction disorder, which has unique features on electrodiagnostic testing. Here we describe a middle aged lady with symmetric, progressive, areflexic weakness in lower limbs, who had the typical electrodiagnostic findings of diffuse attenuation of motor amplitudes, and increase in these amplitudes after brief exercise of the muscl...
متن کاملMantle Cell Lymphoma
American Society of Hematology in the first 2 years has also been reduced by 50% in the rituximab-containing treatment arm. These preliminary findings in a pilot study echo the results of previously published studies in advanced disease and provide a lead for future comparative trials. Although the majority of patients with limited disease can be cured using a brief course of doxorubicincontain...
متن کاملMantle Cell Lymphoma.
Mantle cell lymphoma (MCL) is an uncommon subtype of non-Hodgkin lymphoma previously considered to have a poor prognosis. Large gains were made in the first decade of the new century when clinical trials established the importance of high-dose therapy and autologous stem-cell rescue and high-dose cytarabine in younger patients and the benefits of maintenance rituximab and bendamustine in older ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: GE Portuguese Journal of Gastroenterology
سال: 2015
ISSN: 2341-4545
DOI: 10.1016/j.jpge.2014.12.001